WASHINGTON, D.C. -- In response to presumptive Democratic Presidential Nominee Joe Biden’s choice of Sen. Kamala Harris (D-Calif.) as his running mate for the 2020 Presidential Election, Adam Brandon, FreedomWorks President, commented:

WASHINGTON, D.C. -- As part of our ongoing effort to advance healthcare freedom, Sarah Anderson, FreedomWorks’ Director of Policy, hosted a series of online interviews with elected officials and health policy experts on the need for Congress to expand health savings accounts. Links to the online interviews with H.R. 6338 sponsors Reps. Ted Budd (R-N.C.) and Chip Roy (R-Texas) and Americans for Prosperity’s Dean Clancy are here and here.

WASHINGTON, D.C. -- In response to the House passage of the Patient Protection and Affordable Care Enhancement Act, H.R. 1425, on a largely party-line vote, Jason Pye, FreedomWorks Vice President of Legislative Affairs, commented:

WASHINGTON, D.C. -- Following the passage - by an overwhelming bipartisan majority - of an amendment sponsored by Sens. Mike Lee (R-Utah) and Patrick Leahy (D-Vt.) to increase the involvement of amici curiae in FISA court proceedings and to require that the government disclose exculpatory evidence in such proceedings, Jason Pye, FreedomWorks' Vice President of Legislative Affairs, commented:

WASHINGTON, D.C. -- In response to the Trump Administration’s announcements of CMS loosening regulations for telehealth in Medicare and FDA empowering states on testing in efforts to counter the COVID-19 pandemic, Adam Brandon, FreedomWorks’ President, commented:

WASHINGTON, D.C. -- In response to Sen. Chuck Grassley’s (R-Iowa) most recent support for government mandated price controls on prescription drugs, Dan Savickas, FreedomWorks Regulatory Policy Manager, commented: